Jennison Associates LLC Baxter International Inc Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$37.88 - $43.77 $268,190 - $309,891	-7,080 Reduced 0.9%	776,880 $33.2 Million
Q4 2023 Feb 01, 2024	BUY	$31.71 - $38.95 $203,990 - $250,565	6,433 Added 0.83%	783,960 $30.3 Million
Q3 2023 Oct 31, 2023	BUY	$37.32 - $49.29 $5.13 Million - $6.77 Million	137,395 Added 21.46%	777,527 $29.3 Million
Q2 2023 Aug 03, 2023	BUY	$39.98 - $47.68 $25.6 Million - $30.5 Million	640,132 New	640,132 $29.2 Million
Q1 2018 Apr 20, 2018	SELL	$62.56 - $72.26 $1.67 Million - $1.93 Million	-26,773 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$61.45 - $66.05 $103,236 - $110,964	-1,680 Reduced 5.9%	26,773 $1.73 Million
Q3 2017 Nov 03, 2017	BUY	$59.5 - $64.61 $1.69 Million - $1.84 Million	28,453	28,453 $1.79 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.